Saniona advances two internal programs toward clinic around year-end
Saniona says SAN2668 for severe pediatric epilepsy and SAN2465 for major depressive disorder are targeting phase I initiation around year-end, alongside a partnership portfolio expected to generate cash to support them.
Saniona enters the second half of 2026 with two internal programs heading for the clinic and a partnership portfolio generating the cash to support them.
SAN2668 for severe pediatric epilepsy and SAN2465 for major depressive disorder are both targeting phase I initiation around year-end.
In August…